Longitudinal evaluation assesses prostate cancer screening with PSA and MRI in screened populations, highlighting the need for efficacy and safety data.
Data on the efficacy and safety of screening for prostate cancer with magnetic resonance imaging (MRI) are needed from studies of follow-up screening.
No takes yet. Share an insight, caveat, or question.
Hugosson et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: